Stéphane Brézillon Selected Research

Proteins (Proteins, Gene)

1/2020	Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.
1/2020	Glypican-1 Level Is Elevated in Extracellular Vesicles Released from MC38 Colon Adenocarcinoma Cells Overexpressing Snail.
1/2020	Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.
5/2013	Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins.
9/2009	Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes.
9/2009	Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration.
12/2007	WITHDRAWN: PUBLISHED IN ERROR BY PUBLISHER: Lumican core protein increases melanoma cell adhesion through a beta 1-type integrin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphane Brézillon Research Topics

Disease

20	Neoplasms (Cancer) 11/2021 - 11/2008
16	Melanoma (Melanoma, Malignant) 11/2021 - 12/2007
5	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2013
2	Inflammatory Breast Neoplasms 09/2020 - 12/2018
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2016
1	Alopecia (Baldness) 12/2022
1	Ovarian Epithelial Carcinoma 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Acidosis 01/2020
1	Wounds and Injuries (Trauma) 01/2018
1	Heart Failure 01/2017
1	Experimental Melanoma 01/2017
1	Disease Progression 01/2017
1	Pulmonary Hypertension 08/2016
1	Ascites 08/2016
1	Carcinogenesis 05/2013

Drug/Important Bio-Agent (IBA)

21	LumicanIBA 11/2021 - 12/2007
9	Small Leucine-Rich ProteoglycansIBA 11/2021 - 11/2008
7	CollagenIBA 11/2021 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
6	Peptides (Polypeptides)IBA 09/2021 - 09/2009
5	IntegrinsIBA 11/2021 - 12/2007
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2017
4	lumcorinIBA 09/2021 - 09/2009
3	Estrogen ReceptorsIBA 11/2020 - 01/2017
2	AntibodiesIBA 11/2021 - 01/2020
2	Amino Acids FDA Link 09/2021 - 01/2013
2	Proteoglycans (Proteoglycan)IBA 09/2020 - 01/2017
2	Small Interfering RNA (siRNA)IBA 08/2020 - 10/2010
2	EnzymesIBA 08/2020 - 01/2020
2	CopperIBA 01/2017 - 08/2016
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017 - 08/2016
2	Methionine (L-Methionine)FDA Link 01/2017 - 08/2016
2	Integrin beta1IBA 09/2009 - 01/2008
1	CosmeceuticalsIBA 12/2022
1	Cyclin D1IBA 11/2021
1	C.I. direct red 80IBA 11/2021
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2021
1	GlycosaminoglycansIBA 09/2020
1	Heparitin Sulfate (Heparan Sulfate)IBA 08/2020
1	Cadherins (E-Cadherin)IBA 08/2020
1	Free RadicalsIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	GlypicansIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	ProteomeIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	TAX2 peptideIBA 01/2017
1	DecorinIBA 11/2014
1	AgarIBA 01/2013
1	Extracellular Matrix ProteinsIBA 10/2010
1	Fibronectins (Fibronectin)IBA 09/2009
1	Collagen Type I (Type I Collagen)IBA 09/2009
1	Leucine (L-Leucine)FDA Link 09/2009
1	Protein Isoforms (Isoforms)IBA 11/2008
1	Divalent CationsIBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Intravenous Injections 01/2021
1	Synchrotrons 09/2020
1	Subcutaneous Injections 01/2012